Suchergebnisse - "Bousfield, Rachel"

PubPharm (30)

1

A metagenomic prospective cohort study on gut microbiome composition and clinical infection in small bowel transplantation

enthalten in: Gut microbes | 2024

von Madhav, A. | Bousfield, R. | Pereira-Dias, J. | +19

2

Rapid Detection of Antimicrobial Resistance Genes in Critically Ill Children Using a Custom TaqMan Array Card

enthalten in: Antibiotics (Basel, Switzerland) | 2023

von Clark, J. | Curran, M. | Gouliouris, T. | +8

3

The rapid detection of respiratory pathogens in critically ill children

enthalten in: ResearchSquare.com | 2023

von Clark, J. | Morris, A. | Curran, M. | +16

4

The rapid detection of respiratory pathogens in critically ill children

enthalten in: Critical care (London, England) | 2023

von Clark, J. | Conway Morris, A. | Curran, M. | +16

5

The rapid detection of respiratory pathogens in critically ill children

enthalten in: Critical care | 2023

von Clark, J. | Conway Morris, A. | Curran, M. | +16

6

The rapid detection of respiratory pathogens in critically ill children

enthalten in: Critical care | 2023

von Clark, J. | Conway Morris, A. | Curran, M. | +16

7

A prospective study of risk factors associated with seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a large UK teaching hospital

enthalten in: The Journal of infection | 2022

von Cooper, D. | Lear, S. | Watson, L. | +39

8

Investigation of healthcare-associated SARS-CoV-2 infection : Learning outcomes from an investigative process in the initial phase of the pandemic

enthalten in: Journal of infection prevention | 2022

von Ramsay, I. | Sharrocks, K. | Warne, B. | +17

9

The Removal of Airborne Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Other Microbial Bioaerosols by Air Filtration on Coronavirus Disease 2019 (COVID-19) Surge Units

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Conway Morris, A. | Sharrocks, K. | Bousfield, R. | +18

10

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST) : a multicentre, blinded, phase 2, randomised trial

enthalten in: The Lancet. Infectious diseases | 2022

von Munro, A. | Feng, S. | Janani, L. | +153

CommentIn: Lancet Infect Dis. 2022 Aug;22(8):1092-1093. - PMID 35550263